Archive · 30 Sep 2025
Ozempic's India Launch Imminent for Diabetes, Weight Loss
Ozempic, a medicine for type-2 diabetes, is approved for use in India.
It helps control blood sugar and can assist in weight loss.
The drug works by mimicking a natural hormone.
It is given as a weekly injection.
Common side effects include nausea and diarrhea.
The drug's patent expires next year, potentially lowering costs in the future.
It's expected to be priced similarly to Wegovy.
Ozempic, a semaglutide medication, is approved for use in India.
Novo Nordisk is set to launch Ozempic in India.
The drug is used to manage type-2 diabetes and promote weight loss.
It mimics a hormone that makes you feel full and slows stomach emptying.
Common side effects include nausea, vomiting, and diarrhea.
- Who
- Novo Nordisk
- What
- Approval and launch of Ozempic in India
- When
- Approved; launch expected soon
- Where
- India
- Why
- To treat type-2 diabetes and support weight loss
Benefits
Concerns
Effectiveness
Benefits
Improves blood sugar control and supports weight loss.
Concerns
Potential side effects like nausea and gastrointestinal issues.
- Drug Name
- Ozempic (semaglutide)
- Use
- Type-2 diabetes treatment, weight loss
- Manufacturer
- Novo Nordisk
- India Approval
- Approved for adults with type 2 diabetes
- Administration
- Weekly injection
- Reported Side Effects
- Nausea, vomiting, diarrhea
Sources
Novo Nordisk v Eli Lilly: return of the weight-loss wars
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic, the blockbuster weight-loss drug, coming to India soon: How effective is it?
